Insider Transactions in Q3 2021 at Centene Corp (CNC)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 30
2021
|
H James Dallas Director |
BUY
Grant, award, or other acquisition
|
Direct |
467
+1.74%
|
$30,822
$66.82 P/Share
|
Sep 30
2021
|
Robert K Ditmore Director |
BUY
Grant, award, or other acquisition
|
Direct |
636
+0.1%
|
$41,976
$66.82 P/Share
|
Sep 30
2021
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
467
+0.14%
|
$30,822
$66.82 P/Share
|
Sep 30
2021
|
David L Steward Director |
BUY
Grant, award, or other acquisition
|
Direct |
523
+0.24%
|
$34,518
$66.82 P/Share
|
Sep 30
2021
|
Tommy G Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
523
+0.23%
|
$34,518
$66.82 P/Share
|
Sep 30
2021
|
William L Trubeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
467
+0.51%
|
$30,822
$66.82 P/Share
|
Sep 30
2021
|
John R Roberts Director |
BUY
Grant, award, or other acquisition
|
Direct |
467
+0.22%
|
$30,822
$66.82 P/Share
|
Sep 14
2021
|
Sarah London Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,844
-1.78%
|
$238,328
$62.9 P/Share
|
Sep 07
2021
|
Sarah London Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+33.71%
|
$7,040,000
$64.37 P/Share
|
Sep 07
2021
|
Brent D Layton President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+17.08%
|
$7,040,000
$64.37 P/Share
|
Aug 31
2021
|
Michael F Neidorff Chairman & CEO |
SELL
Bona fide gift
|
Direct |
79,598
-1.2%
|
-
|
Aug 02
2021
|
Brent D Layton President & COO |
SELL
Bona fide gift
|
Direct |
2,500
-0.59%
|
-
|
Jul 29
2021
|
Brent D Layton President & COO |
SELL
Open market or private sale
|
Direct |
4,000
-0.93%
|
$280,000
$70.0 P/Share
|
Jul 29
2021
|
Orlando Ayala Director |
SELL
Open market or private sale
|
Direct |
9,366
-9.34%
|
$655,620
$70.0 P/Share
|
Jul 06
2021
|
David P Thomas CEO, Markets and Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
4,131
-5.15%
|
$301,563
$73.88 P/Share
|
Jul 01
2021
|
David P Thomas CEO, Markets and Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
1,414
-1.73%
|
$101,808
$72.93 P/Share
|